申请人:Parmee R. Emma
公开号:US20060116366A1
公开(公告)日:2006-06-01
The present invention relates to spirocyclic ureas, compositions containing such compounds and methods of treatment The compounds are glucagon receptor antagonists and thus are useful for treating, preventing or delaying the onset of type 2 diabetes mellitus.
本发明涉及螺环脲类化合物、含有此类化合物的组合物以及治疗方法。这些化合物是葡萄糖高原素受体拮抗剂,因此可用于治疗、预防或延迟2型糖尿病的发生。